Published in Int J Gynecol Cancer on February 01, 2016
Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome | NCT05257057
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Two pathogenetic types of endometrial carcinoma. Gynecol Oncol (1983) 6.26
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA (2011) 4.84
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res (2006) 4.26
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet (2009) 3.99
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology (2009) 2.75
Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol (2006) 2.59
Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst (2009) 2.56
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol (2012) 2.40
Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines. Am J Gastroenterol (2005) 2.40
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol (2007) 1.89
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J Clin Oncol (2007) 1.87
Use of mutation profiles to refine the classification of endometrial carcinomas. J Pathol (2012) 1.72
Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control (2009) 1.66
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control (2010) 1.52
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol (2008) 1.49
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol (2005) 1.49
hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol (1999) 1.47
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol (2000) 1.25
Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol (2007) 1.22
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol (2006) 1.18
Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol (2000) 1.16
Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia. Clin Cancer Res (2009) 1.07
Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome. Am J Surg Pathol (2013) 1.05
The genomics and genetics of endometrial cancer. Adv Genomics Genet (2012) 1.03
Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol Histopathol (2006) 1.02
Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol (2007) 1.01
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. Gynecol Oncol (2013) 1.01
The emerging genomic landscape of endometrial cancer. Clin Chem (2013) 0.94
Gynecologic cancers associated with Lynch syndrome/HNPCC. Clin Transl Oncol (2008) 0.94
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol (2013) 0.94
Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer. Mod Pathol (2005) 0.92
MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer (2001) 0.91
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecol Oncol (2010) 0.91
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol (2014) 0.89
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger. Gynecol Oncol (2011) 0.88
Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. Gynecol Oncol (2015) 0.88
Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. PLoS One (2013) 0.87
Hereditary gynaecological malignancies: advances in screening and treatment. Histopathology (2013) 0.86
Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression. Gynecol Oncol (2012) 0.81
Endometrial intraepithelial neoplasia: clinical correlates and outcomes. Obstet Gynecol (2011) 0.79
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer (2013) 0.78
Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci (2014) 0.78
Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma. Int J Gynecol Pathol (2004) 0.77
Clinical usefulness of microsatellite instability test in Korean young patients with high-risk features associated with adenoma. Clin Res Hepatol Gastroenterol (2012) 0.76
Arsenic in drinking water and stroke hospitalizations in Michigan. Stroke (2010) 1.49
Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol (2005) 1.42
Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol (2003) 1.42
Rate and associations of epididymal cysts on pediatric scrotal ultrasound. J Urol (2010) 1.38
Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.26
Comparison of potentially preventable hospitalizations related to diabetes among Native Hawaiian, Chinese, Filipino, and Japanese elderly compared with whites, Hawai'i, December 2006-December 2010. Prev Chronic Dis (2013) 1.06
Predictors of outcome following hip fracture rehabilitation. PM R (2010) 1.06
Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects. Epidemiology (2008) 1.02
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.01
Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol (2004) 0.98
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev (2008) 0.89
Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control (2008) 0.88
Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawai'i. J Immigr Minor Health (2015) 0.87
Is the comparison of a left varicocele testis to its contralateral normal testis sufficient in determining its well-being? Urology (2011) 0.83
Is age at toilet training associated with the presence of vesicoureteral reflux or the occurrence of urinary tract infection? J Urol (2009) 0.82
Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression. Gynecol Oncol (2012) 0.81
Illness severity and psychiatric hospitalization rates among Asian Americans and Pacific Islanders. Psychiatr Serv (2013) 0.81
Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol (2006) 0.81
Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol (2006) 0.80
Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk. Obstet Gynecol (2007) 0.80
Cost Burden of Potentially Preventable Hospitalizations for Cardiovascular Disease and Diabetes for Asian Americans, Pacific Islanders, and Whites in Hawai'i. J Health Care Poor Underserved (2015) 0.78
High rates of Native Hawaiian and older Japanese adults hospitalized with dementia in Hawai'i. J Am Geriatr Soc (2014) 0.77
Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression. Gynecol Oncol (2013) 0.75
Paracervical Block for Laminaria Insertion Before Second-Trimester Abortion: A Randomized Controlled Trial. Obstet Gynecol (2017) 0.75
Non-islet cell tumor hypoglycemia associated with recurrent carcinosarcoma of the ovary. Endocr Pract (2013) 0.75